Inhibition of leukotriene formation as a mode of action of gastroprotective drugs.
Lange
K
K
Department of Pharmacology, Ruhr-University of Bochum, FRG.
Peskar
B A
BA
Peskar
B M
BM
D000818:Animals; D002229:Carbenoxolone / Q000494:pharmacology*; D002396:Catechols / Q000494:pharmacology*; D000431:Ethanol / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D066298:In Vitro Techniques; D008297:Male; D009637:Masoprocol / Q000494:pharmacology*; D011453:Prostaglandins / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013189:SRS-A / Q000378:metabolism*; D013276:Stomach Ulcer / Q000378:metabolism*
D002396:Catechols; D011453:Prostaglandins; D013189:SRS-A; D000431:Ethanol; D009637:Masoprocol; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid